483 Acella Pharmaceuticals Mar 2012

483 Acella Pharmaceuticals Mar 2012

Jawaid Hamid FDA$119.00 - Available Now

FDA investigators audited the Acella Pharmaceuticals - Alpharetta, GA, United States facility and issued 3 inspectional observations (via FDA 483) on 22 Mar 2012.

Product details

  • Category: Human Drugs
  • Number of Observations: 3
  • Inspection end: 22 Mar 2012
  • Location: Alpharetta, United States
  • FEI: 3006691461
Add To Cart